Indoco Remedies is currently trading at Rs. 252.00, up by 9.70 points or 4.00% from its previous closing of Rs. 242.30 on the BSE.
The scrip opened at Rs. 240.75 and has touched a high and low of Rs. 253.55 and Rs. 239.30 respectively. So far 21403 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 332.15 on 11-Sep-2025 and a 52 week low of Rs. 163.70 on 30-Mar-2026.
Last one week high and low of the scrip stood at Rs. 253.55 and Rs. 216.45 respectively. The current market cap of the company is Rs. 2254.98 crore.
The promoters holding in the company stood at 58.86%, while Institutions and Non-Institutions held 18.95% and 22.18% respectively.
Indoco Remedies has executed the Deed of Conveyance for sale of its plot of land admeasuring around 2,876.08 square meters built-up area situated at Mahal Industrial Estate, Village Mulgaon, Taluka Andheri, District Mumbai Suburban. This sale of plot of land would not have any impact on the business operations of the company. The total consideration agreed for sale of land is Rs 64 crore.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
